Kidney cancer: post-surgery sorafenib
0 Views
administrator
06/26/23
Tim Eisen, MBBChir, PhD, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK, describes the rationale and methodology behind the SORCE trial (NCT00492258) and what have we learned at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.
-
Category
Show more
Facebook Comments
No comments found